What will we do?

  • Safeguard the interests of ADD providers in the sphere of human pharmaceuticals.
  • Provide a forum to discuss and share ADD-related issues through communication, networking and the exchange of ideas, experiences and knowledge.
  • Promote ADD as a central aspect of pharmaceutical care.
  • Foster the use of the European Directory for the Quality of Medicines and HealthCare (EDQM) guidelines as the European standard for ADD, especially in countries where standards do not exist or have lower standards.
  • Act as a liaison between European authorities and those at national and local level to provide information and promote ADD as an essential element in the pharmacological management of drugs and help to establish harmonised implementation arrangements.
  • Communicate with members, representative organisations and associations at European, national and local level and governments regarding ADD guidelines and standards and the various activities available.
  • Support the rational use of medications through ADD, foster adherence to prescribed medications and reduce their adverse effects.
  • Provide assistance and support for innovation and technological advances in the world of ADD.
  • Establish regular meetings for EAADD members and/or committees
  • Act as a support and advice platform for members on technical and professional issues.
  • Create a process of certification by audit for the enforcement of standards set by the guidelines and European standards for ADD
  • Provide written updates on ADD through newsletters or by allowing members to access the Association’s website.
  • Supporting awareness of ADD as a core facet of patients pharmaceutical care and improving patients access to ADD
  • Strengthening the use of the EDQM ADD Guidelines as the European standard for ADD and associated patient care, particularly in countries where are no or inferior standards in place
  • Collaborating with relevant European, national and local associations on ADD standards and activities
  • Liaising with and advocating to European, national and local authorities on ADD activities
  • Supporting the rational use of medicines in ADD, including medication adherence, the reduction of adverse medication events and other patient care activities associated with the ADD process
  • Supporting a sustainable ADD infrastructure, wich reduces medication expenditure and waste
  • Supporting ADD innovation and advancements
Become a Member